Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Congestive Heart Failure (CHF) Global Market Report 2025
Download Free Sample Buy Now
Global Congestive Heart Failure CHF Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Congestive Heart Failure (CHF) Global Market Report 2025

By Type (Systolic Heart Failure, Diastolic Failure, Left-Sided Heart Failure, Right-Sided Heart Failure), By Treatment (Medication, Surgery), By Diagnosis (Electrocardiogram, Echocardiogram, Magnetic Resonance Imaging (MRI), Stress Test, Blood Tests, Cardiac Catheterization, Other Diagnosis), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Homecare Settings) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Congestive Heart Failure (CHF) Market Overview

• Congestive Heart Failure (CHF) market size has reached to $15.94 billion in 2024

• Expected to grow to $21.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%

• Growth Driver: Rising Cardiovascular Cases Fuel Demand For Advanced Heart Failure Solutions

• Market Trend: Advancing Gene Therapy For Congestive Heart Failure With Precision Treatments

• North America was the largest region in 2024 and Asia Pacific is the fastest growing region.

What Is Covered Under Congestive Heart Failure (CHF) Market?

Congestive heart failure (CHF) is a chronic and progressive condition where the heart's ability to pump blood effectively is compromised, leading to a backup of fluid in the lungs, heart, liver, and other parts of the body, causing symptoms such as shortness of breath, fatigue, swelling, and difficulty in performing daily activities, ultimately impacting the overall quality of life and requiring ongoing medical management and treatment.

The main types of congestive heart failure (CHF) include systolic heart failure, diastolic failure, left-sided heart failure, and right-sided heart failure. Systolic heart failure occurs when the heart muscle's ability to pump blood is impaired, resulting in inadequate blood circulation. The various treatments include medication and surgery with various diagnostic methods such as electrocardiogram, echocardiogram, magnetic resonance imaging (mri), stress test, blood tests, cardiac catheterization, other diagnosis. These are distributed through various distribution channels such as hospital pharmacy, online pharmacy, retail pharmacy that are used by various end-users such as hospitals, specialty clinics, ambulatory surgical centers, homecare settings.

Congestive Heart Failure (CHF) Market Size and growth rate 2025 to 2029: Graph

What Is The Congestive Heart Failure (CHF) Market Size 2025 And Growth Rate?

The congestive heart failure (CHF) market size has grown strongly in recent years. It will grow from $15.94 billion in 2024 to $16.94 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to high prevalence of aging population, increasing cardiovascular diseases, rise in awareness of heart health, increasing healthcare expenditure, growth demand for remote patient monitoring.

What Is The Congestive Heart Failure (CHF) Market Growth Forecast?

The congestive heart failure (CHF) market size is expected to see strong growth in the next few years. It will grow to $21.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to rising adoption of digital health solutions, increasing prevalence of hypertension, rising obesity rates, improving patient outcomes, increased focus on personalized medicine. Major trends in the forecast period include advancements in diagnostic technologies, advancements in treatment options, technological advancements in imaging, innovations in therapeutic approaches, developments in wearable health devices.

The forecast of 6.5% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. cardiac care by increasing costs for ventricular assist devices and natriuretic peptide tests imported from Sweden and Italy, potentially worsening outcomes and raising heart failure clinic expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Congestive Heart Failure (CHF) Market Segmented?

1) By Type: Systolic Heart Failure, Diastolic Failure, Left-Sided Heart Failure, Right-Sided Heart Failure

2) By Treatment: Medication, Surgery

3) By Diagnosis: Electrocardiogram, Echocardiogram, Magnetic Resonance Imaging (MRI), Stress Test, Blood Tests, Cardiac Catheterization, Other Diagnosis

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Homecare Settings

Subsegments:

1) By Systolic Heart Failure: Reduced Ejection Fraction (HFrEF), Mild-to-moderate Reduced Ejection Fraction

2) By Diastolic Heart Failure: Preserved Ejection Fraction (HFpEF), Borderline Ejection Fraction (HFpEF)

3) By Left-Sided Heart Failure: Acute Left-Sided Heart Failure, Chronic Left-Sided Heart Failure

4) By Right-Sided Heart Failure: Acute Right-Sided Heart Failure, Chronic Right-Sided Heart Failure

What Is Driving The Congestive Heart Failure (CHF) Market? Rising Cardiovascular Cases Fuel Demand For Advanced Heart Failure Solutions

The increase in cardiovascular patients is expected to propel the growth of the congestive heart failure (CHF) market going forward. Cardiovascular refers to the heart and blood vessels, focusing on their role in circulating blood and maintaining the body's overall health. The rise in cardiovascular patients is due to sedentary lifestyles, unhealthy diets, ageing populations, and urbanization, leading to a higher need for advanced healthcare and treatment solutions. Congestive heart failure (CHF) is helpful for cardiovascular patients by providing targeted solutions that improve heart efficiency, reduce symptoms, and prevent complications, ultimately enhancing patient care and overall well-being. For instance, in January 2023, according to the American College of Cardiology, a US-based nonprofit medical society, cardiovascular disease cases rose to 19.8 million in 2022. Additionally, Eastern Europe has the highest mortality rate at 553 deaths per 100,000. Therefore, the increase in cardiovascular patients is driving growth in the congestive heart failure (CHF) industry.

Who Are The Major Players In The Global Congestive Heart Failure (CHF) Market?

Major companies operating in the congestive heart failure (CHF) market are Pfizer Inc., Johnson & Johnson Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG., Medtronic Plc, Eli Lilly and Company, Canon Medical Systems Corporation, Novo Nordisk A/S, Jarvik Heart Inc., Boston Scientific Corporation, Applied Molecular Genetics Inc., Biotronik SE & Co. KG, Exelixis Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., LivaNova

What Are The Key Trends Of The Global Congestive Heart Failure (CHF) Market? Advancing Gene Therapy For Congestive Heart Failure With Precision Treatments

Major companies operating in the congestive heart failure (CHF) market are focusing on advanced innovations, such as single intracoronary infusion therapies to offer effective treatment options that improve heart function and enhance the quality of life for CHF patients. Single intracoronary infusion delivers medication directly into the coronary artery, targeting the heart to provide precise treatment for conditions like congestive heart failure (CHF). For instance, in January 2024, Bayer AG, a Germany-based pharmaceutics company, and Asklepios Biopharmaceutical, Inc., a US-based biotechnology company, initiated the GenePHIT Phase II trial for AB-1002, an investigational gene therapy for congestive heart failure (CHF). This innovation utilizes a gene therapy approach to target non-ischemic cardiomyopathy, offering a potential breakthrough in the treatment of CHF through advanced genetic solutions. The trial is adaptive, double-blind, placebo-controlled, and will enroll between 90 and 150 participants who have been medically stable for at least four weeks and have a left ventricular ejection fraction between 15% and 35%.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Congestive Heart Failure (CHF) Market? Johnson & Johnson Acquires V-Wave Ltd. to Strengthen Cardiovascular MedTech Portfolio

In October 2024, Johnson & Johnson a US-pharmaceutical company acquired V-Wave Ltd. for an undisclosed amount. This acquisition enables Johnson & Johnson to expand its MedTech portfolio in cardiovascular care, specifically addressing heart failure with the novel Ventura Interatrial Shunt. V-Wave Ltd. is an Israel-based company focused on developing innovative treatment options for patients with congestive heart failure.

What Is The Regional Outlook For The Global Congestive Heart Failure (CHF) Market?

North America was the largest region in the congestive heart failure (CHF) market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Congestive Heart Failure (CHF) Market?

The congestive heart failure (CHF) market consists of revenues earned by entities by providing cardiac treatment, hemodynamic monitoring, and therapeutic services. The market value includes the value of related goods such as diagnostic tools, monitoring devices, and support services. The congestive heart failure (CHF) market also includes sales of diagnostic tools, and testing kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Congestive Heart Failure (CHF) Industry?

The congestive heart failure (chf) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the congestive heart failure (chf) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Congestive Heart Failure (CHF) Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $16.94 billion
Revenue Forecast In 2034 $21.79 billion
Growth Rate CAGR of 6.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The congestive heart failure (CHF) market covered in this report is segmented –
1) By Type: Systolic Heart Failure, Diastolic Failure, Left-Sided Heart Failure, Right-Sided Heart Failure
2) By Treatment: Medication, Surgery
3) By Diagnosis: Electrocardiogram, Echocardiogram, Magnetic Resonance Imaging (MRI), Stress Test, Blood Tests, Cardiac Catheterization, Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Homecare Settings Subsegments:
1) By Systolic Heart Failure: Reduced Ejection Fraction (HFrEF), Mild-to-moderate Reduced Ejection Fraction
2) By Diastolic Heart Failure: Preserved Ejection Fraction (HFpEF), Borderline Ejection Fraction (HFpEF)
3) By Left-Sided Heart Failure: Acute Left-Sided Heart Failure, Chronic Left-Sided Heart Failure
4) By Right-Sided Heart Failure: Acute Right-Sided Heart Failure, Chronic Right-Sided Heart Failure
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG., Medtronic Plc, Eli Lilly and Company, Canon Medical Systems Corporation, Novo Nordisk A/S, Jarvik Heart Inc., Boston Scientific Corporation, Applied Molecular Genetics Inc., Biotronik SE & Co. KG, Exelixis Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., LivaNova
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Congestive Heart Failure (CHF) Market Characteristics

3. Congestive Heart Failure (CHF) Market Trends And Strategies

4. Congestive Heart Failure (CHF) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Congestive Heart Failure (CHF) Growth Analysis And Strategic Analysis Framework

5.1. Global Congestive Heart Failure (CHF) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Congestive Heart Failure (CHF) Market Growth Rate Analysis

5.4. Global Congestive Heart Failure (CHF) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Congestive Heart Failure (CHF) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Congestive Heart Failure (CHF) Total Addressable Market (TAM)

6. Congestive Heart Failure (CHF) Market Segmentation

6.1. Global Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Systolic Heart Failure

Diastolic Failure

Left-Sided Heart Failure

Right-Sided Heart Failure

6.2. Global Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medication

Surgery

6.3. Global Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Electrocardiogram

Echocardiogram

Magnetic Resonance Imaging (MRI)

Stress Test

Blood Tests

Cardiac Catheterization

Other Diagnosis

6.4. Global Congestive Heart Failure (CHF) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

6.5. Global Congestive Heart Failure (CHF) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

Homecare Settings

6.6. Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Systolic Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Reduced Ejection Fraction (HFrEF)

Mild-to-moderate Reduced Ejection Fraction

6.7. Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Diastolic Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Preserved Ejection Fraction (HFpEF)

Borderline Ejection Fraction (HFpEF)

6.8. Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Left-Sided Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute Left-Sided Heart Failure

Chronic Left-Sided Heart Failure

6.9. Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Right-Sided Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute Right-Sided Heart Failure

Chronic Right-Sided Heart Failure

7. Congestive Heart Failure (CHF) Market Regional And Country Analysis

7.1. Global Congestive Heart Failure (CHF) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Congestive Heart Failure (CHF) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Congestive Heart Failure (CHF) Market

8.1. Asia-Pacific Congestive Heart Failure (CHF) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Congestive Heart Failure (CHF) Market

9.1. China Congestive Heart Failure (CHF) Market Overview

9.2. China Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Congestive Heart Failure (CHF) Market

10.1. India Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Congestive Heart Failure (CHF) Market

11.1. Japan Congestive Heart Failure (CHF) Market Overview

11.2. Japan Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Congestive Heart Failure (CHF) Market

12.1. Australia Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Congestive Heart Failure (CHF) Market

13.1. Indonesia Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Congestive Heart Failure (CHF) Market

14.1. South Korea Congestive Heart Failure (CHF) Market Overview

14.2. South Korea Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Congestive Heart Failure (CHF) Market

15.1. Western Europe Congestive Heart Failure (CHF) Market Overview

15.2. Western Europe Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Congestive Heart Failure (CHF) Market

16.1. UK Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Congestive Heart Failure (CHF) Market

17.1. Germany Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Congestive Heart Failure (CHF) Market

18.1. France Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Congestive Heart Failure (CHF) Market

19.1. Italy Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Congestive Heart Failure (CHF) Market

20.1. Spain Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Congestive Heart Failure (CHF) Market

21.1. Eastern Europe Congestive Heart Failure (CHF) Market Overview

21.2. Eastern Europe Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Congestive Heart Failure (CHF) Market

22.1. Russia Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Congestive Heart Failure (CHF) Market

23.1. North America Congestive Heart Failure (CHF) Market Overview

23.2. North America Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Congestive Heart Failure (CHF) Market

24.1. USA Congestive Heart Failure (CHF) Market Overview

24.2. USA Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Congestive Heart Failure (CHF) Market

25.1. Canada Congestive Heart Failure (CHF) Market Overview

25.2. Canada Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Congestive Heart Failure (CHF) Market

26.1. South America Congestive Heart Failure (CHF) Market Overview

26.2. South America Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Congestive Heart Failure (CHF) Market

27.1. Brazil Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Congestive Heart Failure (CHF) Market

28.1. Middle East Congestive Heart Failure (CHF) Market Overview

28.2. Middle East Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Congestive Heart Failure (CHF) Market

29.1. Africa Congestive Heart Failure (CHF) Market Overview

29.2. Africa Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Congestive Heart Failure (CHF) Market Competitive Landscape And Company Profiles

30.1. Congestive Heart Failure (CHF) Market Competitive Landscape

30.2. Congestive Heart Failure (CHF) Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Congestive Heart Failure (CHF) Market Other Major And Innovative Companies

31.1. Sanofi S.A.

31.2. Bristol-Myers Squibb Company

31.3. Abbott Laboratories

31.4. Novartis AG.

31.5. Medtronic Plc

31.6. Eli Lilly and Company

31.7. Canon Medical Systems Corporation

31.8. Novo Nordisk A/S

31.9. Jarvik Heart Inc.

31.10. Boston Scientific Corporation

31.11. Applied Molecular Genetics Inc.

31.12. Biotronik SE & Co. KG

31.13. Exelixis Pharmaceuticals Inc.

31.14. Otsuka Pharmaceutical Co. Ltd.

31.15. LivaNova

32. Global Congestive Heart Failure (CHF) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Congestive Heart Failure (CHF) Market

34. Recent Developments In The Congestive Heart Failure (CHF) Market

35. Congestive Heart Failure (CHF) Market High Potential Countries, Segments and Strategies

35.1 Congestive Heart Failure (CHF) Market In 2029 - Countries Offering Most New Opportunities

35.2 Congestive Heart Failure (CHF) Market In 2029 - Segments Offering Most New Opportunities

35.3 Congestive Heart Failure (CHF) Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Congestive Heart Failure (CHF) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Congestive Heart Failure (CHF) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Systolic Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Diastolic Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Left-Sided Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Right-Sided Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Congestive Heart Failure (CHF) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Congestive Heart Failure (CHF) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Pfizer Inc. Financial Performance
  • Table 81: Johnson & Johnson Inc. Financial Performance
  • Table 82: Boehringer Ingelheim International GmbH Financial Performance
  • Table 83: Merck & Co. Inc. Financial Performance
  • Table 84: Bayer AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Congestive Heart Failure (CHF) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Congestive Heart Failure (CHF) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Systolic Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Diastolic Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Left-Sided Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Right-Sided Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Congestive Heart Failure (CHF) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Congestive Heart Failure (CHF) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Pfizer Inc. Financial Performance
  • Figure 81: Johnson & Johnson Inc. Financial Performance
  • Figure 82: Boehringer Ingelheim International GmbH Financial Performance
  • Figure 83: Merck & Co. Inc. Financial Performance
  • Figure 84: Bayer AG Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Congestive Heart Failure (CHF) Global Market Report 2025 – By Type (Systolic Heart Failure, Diastolic Failure, Left-Sided Heart Failure, Right-Sided Heart Failure), By Treatment (Medication, Surgery), By Diagnosis (Elect...

View Report

Congestive Heart Failure Treatment Devices Global Market Report 2025 – By Product (Cardiac Pacemaker, Implantable Cardioverter Defibrillators (ICDs), Cardiac Resynchronization Therapy Devices (CRT), Counter Pulsation Dev...

View Report

Congenital Heart Disease (CHD) Global Market Report 2025 – By Type (Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types), By Diagnosis (Electrocardiogram, Chest X-ray,  Echocardiogram, Transesophag...

View Report

Structural Heart Global Market Report 2025 – By Product (Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products), By Procedure (Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure)...

View Report

Heart Attack Diagnostic Global Market Report 2025 – By Test Type( Electrocardiogram (ECG/EKG), Blood Tests, X-Ray, Echocardiogram, Coronary Catheterization (Angiogram), Exercise Stress Test, Magnetic Resonance Imaging (M...

View Report

Cardiac Valve Global Market Report 2025 – By Type (Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves, Other Types), By Position (Aortic Valve, Mitral Valve, Other Positions), By Treatment (Cardiac ...

View Report

Cardiac Biomarkers Global Market Report 2025 – By Biomarkers Type (Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarker Types), By Loca...

View Report

Ventricular Fibrillation Global Market Report 2025 – By Treatment (Cardiopulmonary Resuscitation (CPR), Defibrillation, Medication, Catheter Ablation, Left Cardiac Sympathetic Denervation), By Diagnostic Techniques (Elec...

View Report

Frequently Asked Questions

Congestive heart failure (CHF) is a chronic and progressive condition where the heart's ability to pump blood effectively is compromised, leading to a backup of fluid in the lungs, heart, liver, and other parts of the body, causing symptoms such as shortness of breath, fatigue, swelling, and difficulty in performing daily activities, ultimately impacting the overall quality of life and requiring ongoing medical management and treatment. For further insights on this market, request a sample here

The market major growth driver - Rising Cardiovascular Cases Fuel Demand For Advanced Heart Failure Solutions. For further insights on this market, request a sample here

The congestive heart failure (chf) market size has grown strongly in recent years. It will grow from $15.94 billion in 2024 to $16.94 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to high prevalence of aging population, increasing cardiovascular diseases, rise in awareness of heart health, increasing healthcare expenditure, growth demand for remote patient monitoring. The congestive heart failure (chf) market size is expected to see strong growth in the next few years. It will grow to " $21.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to rising adoption of digital health solutions, increasing prevalence of hypertension, rising obesity rates, improving patient outcomes, increased focus on personalized medicine. Major trends in the forecast period include advancements in diagnostic technologies, advancements in treatment options, technological advancements in imaging, innovations in therapeutic approaches, developments in wearable health devices. For further insights on this market, request a sample here

The congestive heart failure (chf)market covered in this report is segmented –
1) By Type: Systolic Heart Failure; Diastolic Failure; Left-Sided Heart Failure; Right-Sided Heart Failure
2) By Treatment: Medication; Surgery
3) By Diagnosis: Electrocardiogram; Echocardiogram; Magnetic Resonance Imaging (MRI); Stress Test; Blood Tests; Cardiac Catheterization; Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
5) By End-User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Homecare Settings Subsegments:
1) By Systolic Heart Failure: Reduced Ejection Fraction (HFrEF); Mild-to-moderate Reduced Ejection Fraction
2) By Diastolic Heart Failure: Preserved Ejection Fraction (HFpEF); Borderline Ejection Fraction (HFpEF)
3) By Left-Sided Heart Failure: Acute Left-Sided Heart Failure; Chronic Left-Sided Heart Failure
4) By Right-Sided Heart Failure: Acute Right-Sided Heart Failure; Chronic Right-Sided Heart Failure For further insights on this market, request a sample here

North America was the largest region in the congestive heart failure (CHF) market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congestive heart failure (CHF) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the congestive heart failure (CHF) market are Pfizer Inc., Johnson & Johnson Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG., Medtronic Plc, Eli Lilly and Company, Canon Medical Systems Corporation, Novo Nordisk A/S, Jarvik Heart Inc., Boston Scientific Corporation, Applied Molecular Genetics Inc., Biotronik SE & Co. KG, Exelixis Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., LivaNova . For further insights on this market, request a sample here.

Major trends in this market include Advancing Gene Therapy For Congestive Heart Failure With Precision Treatments. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Congestive Heart Failure CHF Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon